239 related articles for article (PubMed ID: 21695775)
1. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions.
Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G
Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids.
Sayed DM; el-Attar MM; Hussein AA
Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060
[TBL] [Abstract][Full Text] [Related]
3. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
Pillai V; Cibas ES; Dorfman DM
Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.
Risberg B; Davidson B; Dong HP; Nesland JM; Berner A
J Clin Pathol; 2000 Jul; 53(7):513-7. PubMed ID: 10961174
[TBL] [Abstract][Full Text] [Related]
5. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.
Krishan A; Ganjei-Azar P; Jorda M; Hamelik RM; Reis IM; Nadji M
Diagn Cytopathol; 2006 Aug; 34(8):528-41. PubMed ID: 16850481
[TBL] [Abstract][Full Text] [Related]
6. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
Kundu R; Handa U; Mohan H
Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
[TBL] [Abstract][Full Text] [Related]
7. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases.
Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B
Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861
[TBL] [Abstract][Full Text] [Related]
8. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls.
Dong HP; Holth A; Berner A; Davidson B; Risberg B
Cytometry B Clin Cytom; 2007 Sep; 72(5):332-43. PubMed ID: 17226863
[TBL] [Abstract][Full Text] [Related]
11. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
12. Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry.
Risberg B; Davidson B; Nielsen S; Dong HP; Christensen J; Johansen P; Asschenfeldt P; Berner A
Diagn Cytopathol; 2001 Oct; 25(4):214-9. PubMed ID: 11599103
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions.
Czader M; Ali SZ
Diagn Cytopathol; 2003 Aug; 29(2):74-8. PubMed ID: 12889043
[TBL] [Abstract][Full Text] [Related]
14. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
15. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping.
Sigstad E; Dong HP; Nielsen S; Berner A; Davidson B; Risberg B
Diagn Cytopathol; 2005 Nov; 33(5):325-31. PubMed ID: 16240402
[TBL] [Abstract][Full Text] [Related]
17. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
[TBL] [Abstract][Full Text] [Related]
18. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions.
Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M
Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433
[TBL] [Abstract][Full Text] [Related]
19. Flow immunocytochemistry of marker expression in cells from body cavity fluids.
Krishan A; Ganjei-Azar P; Hamelik R; Sharma D; Reis I; Nadji M
Cytometry A; 2010 Feb; 77(2):132-43. PubMed ID: 19899128
[TBL] [Abstract][Full Text] [Related]
20. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
